Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

Gastroenterology

Volumn 124, Issue 1, 2003, Pages 71-79

  Ruhl, Constance E ^a   Everharty, James E ^b  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN BLOOD LEVEL; IRON OVERLOAD; LABORATORY TEST; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NUTRITION; OBESITY; PHLEBOTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0037221394     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50004     Document Type: Article

References (48)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.
2. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
3. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-723.
4. Kral JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993;42:548-551.
5. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes 1995;19:846-850.
6. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
8. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373-379.
9. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002;35:367-372.
10. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-1517.
11. Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, Lurie Y, Bass DD. Fatty liver - An additional and treatable feature of the insulin resistance syndrome. Q J Med 1999;92:73-79.
12. Acosta D, Wenzel DG. Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscle and endothelial cells. Atherosclerosis 1974;20:417-426.
13. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-2562.
14. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998;114:842-845.
15. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
16. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
17. Ruhl CE, Everhart JE. Leptin concentrations in the United States: Relations with demographic and anthropometric measures. Am J Clin Nutr 2001;74:295-301.
18. Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000;95:3584-3589.
19. 2(1)collagen gene in hepatic stellate cells (abstr). Hepatology 2001;34:359A.
20. Honda H, Ikejima K, Hirose M, Khamura T, Takel Y, Sato N. Leptin is required for profibrogenic responses in the liver induced by thioacetamide (abstr). Hepatology 2001;34:360A.
21. Yamashina S, Ikejima K, Yoshikawa M, Enomoto N, Hirose M, Kitamura T, Takei Y, Sato N. Kupffer cells contain a functional leptin receptor through which leptin up-regulates transforming growth factor (TGF)-beta production (abstr). Hepatology 2001;34:402A.
22. Ikejima K, Lang T, Yoshikawa M, Zhang Y-J, Kon K, Kitamura T, Takei Y, Sato N. Hepatic stellate cells from leptin receptor-deficient Zucker rats undergo a normal transactivation process in vitro (abstr). Hepatology 2001;34:443A.
23. Daniel S, Ben Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999;94:3010-3014.
24. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics. Vital Health Stat 1994.
25. Harris MI, Cowie CC, Gu K, Francis ME, Flegal K, Eberhardt MS. Higher fasting insulin but lower fasting C-peptide levels in African Americans in the US population. Diabetes Metab Res Rev 2002;18:149-155.
26. U.S. Department of Health and Human Services (DHHS), National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III (CD-ROM). National Health and Nutrition Examination Survey III, 1988-94 (NCHS CD-ROM). Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
27. National Health and Nutrition Examination Survey III: Body measurements (anthropometry). Westat, 1988.
28. National Health and Nutrition Examination Survey III Cycle 2: Pulse and blood pressure procedures for household interviewers. Westat, 1989.
29. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
30. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-946.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
32. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190-198.
33. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health, 2001. NIH Publication 01-3670.
34. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
35. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Salli Paffenbarger RS Jr. Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
36. Research Triangle Institute. SUDAN User's Manual Release 7.0. Research Triangle Park, NC: Research Triangle Institute, April 1996.
37. Last JM, ed. A Dictionary of Epidemiology. 3rd Ed. New York: Oxford University Press, 1995:126.
38. Prati D, Taioli E, Zanella A, Torre ED, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
39. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998;22:39-47.
40. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.
41. Meek SE, Nair KS, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999;48:10-14.
42. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-1062.
43. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 1989;20:594-598.
44. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
45. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994;1070:1103-1109.
46. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.
47. Caldwell SH, Harris DM, Patrie JT, Hespenheide EE. Is NASH underdiagnosed among African Americans? Am J Gastroenterol 2002;97:1496-1500.
48. Kemmer N, McKinney K, Xiao S, Singh H, Murray R, Abdo B, Eledrisi M, Bikkina R, Ma H, Lau D. High prevalence of nonalcoholic steatohepatitis among Mexican American females with type II diabetes mellitus (abstr). Gastroenterology 2001;120:A117.